NCT07184125

Effect of Midazolam as Premedication in Patients Undergoing Breast Conservation Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 124 (actual)
• Sponsor: Shaukat Khanum Memorial Cancer Hospital & Research Centre · Academic / Other
• Sex: Female
• Age: 60 Years
• Healthy volunteers: Not accepted

Summary

Patient are randomized into 2 groups under computer registered numbers. Patient anxiety score is calculated through APAIS SCORE. Then one group is given Midazolam, and the other group is given normal saline and then after one day patients satisfaction is calculated through Lppsq scale.

Detailed description

Patient are randomized into 2 groups under computer registered numbers. After taking approval from hospital ethical committee, 124 females fulfilling inclusion criteria are selected. All patients will receive written information about the study on the day before surgery and before signing informed consent. Patient anxiety score is calculated through APAIS SCORE. Then one group is given Midazolam, and the other group is given normal saline and then after one day patients satisfaction is calculated through Lppsq scale.

Conditions

• Anxiety

Interventions

Type	Name	Description
DRUG	To measure anxiolysis, satisfaction level of patient after receiving Midazolam	Anxiety \& satisfaction

Timeline

• Start date: 2024-08-30
• Primary completion: 2025-09-10
• Completion: 2025-09-10
• First posted: 2025-09-19
• Last updated: 2026-01-08

Locations

1 site across 1 country: Pakistan